4g6k: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_4g6k| PDB=4g6k | SCENE= }} | {{STRUCTURE_4g6k| PDB=4g6k | SCENE= }} | ||
===Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state=== | ===Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state=== | ||
{{ABSTRACT_PUBMED_23041424}} | {{ABSTRACT_PUBMED_23041424}} | ||
==About this Structure== | ==About this Structure== | ||
[[4g6k]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4G6K OCA]. | [[4g6k]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4G6K OCA]. | ||
==Reference== | |||
<ref group="xtra">PMID:023041424</ref><references group="xtra"/><references/> | |||
[[Category: Blech, M.]] | [[Category: Blech, M.]] | ||
[[Category: Hoerer, S.]] | [[Category: Hoerer, S.]] | ||
Revision as of 04:27, 18 July 2013
Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state
Template:ABSTRACT PUBMED 23041424
About this Structure
4g6k is a 2 chain structure. Full crystallographic information is available from OCA.
Reference
- Blech M, Peter D, Fischer P, Bauer MM, Hafner M, Zeeb M, Nar H. One Target-Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1beta J Mol Biol. 2012 Oct 3. pii: S0022-2836(12)00786-3. doi:, 10.1016/j.jmb.2012.09.021. PMID:23041424 doi:10.1016/j.jmb.2012.09.021
